GENERICS AND SPECIALITIES LTD — Azithromycin Importer Profile
Pharmaceutical Importer · #1 buyer for Azithromycin · $611.5K import value · 22 shipments · NIGERIA · DGFT Verified
GENERICS AND SPECIALITIES LTD is the #1 importer of Azithromycin from India with $611.5K in import value and 22 verified shipments. GENERICS AND SPECIALITIES LTD holds a 0.6% market share in Azithromycin imports based in NIGERIA. The company sources from 3 verified suppliers across 10 formulations shipped to 3 countries.
GENERICS AND SPECIALITIES LTD — Azithromycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Azithromycin to GENERICS AND SPECIALITIES LTD?
Verified from 22 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| LINCOLN PHARMACEUTICALS LIMITED | $473.7K | 17 | 77.5% |
| SCOTT EDIL PHARMACIA LIMITED | $100.0K | 2 | 16.4% |
| ZIM LABORATORIES LIMITED | $37.9K | 3 | 6.2% |
GENERICS AND SPECIALITIES LTD sources Azithromycin from 3 verified Indian suppliers based on 22 customs records. The primary supplier is LINCOLN PHARMACEUTICALS LIMITED accounting for 77.5% of imports.
How Does GENERICS AND SPECIALITIES LTD Compare to Nearest Azithromycin Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | HEKO PHARMACY LTD | TANZANIA | $900.0K | 18 | $50.0K |
| 9 | NUEVOS ETICOS NEOETHICALS, S.A. | GUATEMALA | $900.0K | 18 | $50.0K |
| 1 | GENERICS AND SPECIALITIES LTD ★ | NIGERIA | $850.0K | 17 | $50.0K |
| 5 | RADIAN PHARMACEUTICALS LTD | ZAMBIA | $550.0K | 11 | $50.0K |
| 2 | HAWKARY PHARMACEUTICAL COMPANY# | IRAQ | $300.0K | 6 | $50.0K |
GENERICS AND SPECIALITIES LTD ranks #1 among 2,397 Azithromycin importers from India. Average shipment value of $50.0K compared to the market average of $10.4K. The closest competitors by value are HEKO PHARMACY LTD and NUEVOS ETICOS NEOETHICALS, S.A..
Where Does GENERICS AND SPECIALITIES LTD Import Azithromycin To?
Destination countries from 22 verified shipments
GENERICS AND SPECIALITIES LTD imports Azithromycin to 3 countries. The primary destination is NIGERIA receiving 77.5% of shipments worth $473.7K.
What Azithromycin Formulations Does GENERICS AND SPECIALITIES LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| Azithromycin Oral Suspension 200 mg/5 ml | $157.7K | 4 |
| Azithromycin Tablets USP (Zithrolin-250) | $140.0K | 5 |
| Azithromycin Tablets USP (Zithrolin-500) | $130.3K | 5 |
| PHARMACEUTICALS PRODUCTS FORMULATION AZITHROMYCIN ORAL SUSP 200MG/5ML B NO.2317847L004 | $50.0K | 1 |
| PHARMACEUTICALS PRODUCTS FORMULATION AZITHROMYCIN FOR ORAL SUSP. 200MG/5ML B NO.2317847L003 2317847L005 2317847L006 | $50.0K | 1 |
| AZITO SUSPENSION [AZITHROMYCIN FOR ORAL | $32.9K | 2 |
| AZITHROMYCIN TABLETS USP (ZITHROLIN-500)(50681X1X3 TAB) | $23.4K | 1 |
| AZITHROMYCIN ORAL SUSPENSION 200 MG/5 ML | $12.0K | 1 |
| AZITHROMYCIN ORAL SUSPENSION 200 MG/5 ML(ZITHROLIN)(17660X30 ML)NOS | $10.4K | 1 |
| AZITO 500(AZITHROMYCIN TABLETS USP 500 M | $4.9K | 1 |
GENERICS AND SPECIALITIES LTD imports 10 distinct Azithromycin formulations from India. The top formulation is Azithromycin Oral Suspension 200 mg/5 ml with 4 shipments worth $157.7K.
Regulatory Requirements: Importing Azithromycin into Nigeria
What GENERICS AND SPECIALITIES LTD and other importers must comply with to import Azithromycin from India
Regulatory Authority
National Agency for Food and Drug Administration and Control (NAFDAC)
Approval Process for Generic Azithromycin
Drug registration under NAFDAC guidelines. Requires quality data, stability studies, and WHO-type Certificate of Pharmaceutical Product (CPP) from India.
Typical timeline: 6–18 months
GMP Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Import Licence & Documentation
NAFDAC import permit; Certificate of Pharmaceutical Product (CPP) from CDSCO India
Labeling & Packaging
English language labeling; NAFDAC registration number required
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified inspections of Indian sites in recent years.
Regulatory information is provided for general reference based on publicly available NAFDAC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with NAFDAC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Azithromycin from India and How Much Does GENERICS AND SPECIALITIES LTD Import?
India exported $24.8M worth of Azithromycin through 15,000 shipments from 853 suppliers to 169 countries, serving 2,397 buyers globally. GENERICS AND SPECIALITIES LTD imports $611.5K of this total, accounting for 0.6% of India's Azithromycin exports with 22 shipments from NIGERIA. This is verified from 22 customs shipment records covering 10 distinct formulations.
What Is the Average Order Value for GENERICS AND SPECIALITIES LTD's Azithromycin Imports?
GENERICS AND SPECIALITIES LTD's average Azithromycin order value is $27.8K per consignment, based on 22 shipments totaling $611.5K. GENERICS AND SPECIALITIES LTD is based in NIGERIA and ranks #1 among all Azithromycin importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Azithromycin to GENERICS AND SPECIALITIES LTD?
GENERICS AND SPECIALITIES LTD sources Azithromycin from 3 verified Indian suppliers: LINCOLN PHARMACEUTICALS LIMITED ($473.7K, 77.5%), SCOTT EDIL PHARMACIA LIMITED ($100.0K, 16.4%), ZIM LABORATORIES LIMITED ($37.9K, 6.2%). This is based on 22 customs records.
How Does GENERICS AND SPECIALITIES LTD Compare to Other Azithromycin Importers?
GENERICS AND SPECIALITIES LTD ranks #1 among 2,397 Azithromycin importers from India with a 0.6% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($5.8M), J. KNIPPER & COMPANY ($3.1M), PLANETPHARMA ($2.5M). GENERICS AND SPECIALITIES LTD processed 22 shipments from NIGERIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Azithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Azithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: GENERICS AND SPECIALITIES LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as GENERICS AND SPECIALITIES LTD's capped import value divided by total capped export value for Azithromycin across all Indian exporters.
- 5.Verified Records: This page is backed by 22 individual customs records matching GENERICS AND SPECIALITIES LTD importing Azithromycin, covering 10 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 169+ countries, 2,397+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Azithromycin Import Data for GENERICS AND SPECIALITIES LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for GENERICS AND SPECIALITIES LTD's Azithromycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GENERICS AND SPECIALITIES LTD
Company Profile
Multiple products · $0 total trade · Multiple categories
GENERICS AND SPECIALITIES LTD × Azithromycin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for GENERICS AND SPECIALITIES LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Azithromycin. For current order-level data, contact TransData Nexus.